ESCROW AGREEMENT FOR SECURITIES OFFERINGEscrow Agreement • July 8th, 2020 • 20/20 GeneSystems, Inc. • Services-testing laboratories • Delaware
THIS ESCROW AGREEMENT, dated as of 6/17/20 (“Escrow Agreement”), is by and between SI Securities, LLC (“SI Securities”), 20/20 GeneSystems, Inc., a Delaware corporation (“Issuer”), and The Bryn Mawr Trust Company of Delaware (“BMTC DE”), a Delaware entity, as Escrow Agent hereunder (“Escrow Agent”). Capitalized terms used herein, but not otherwise defined, shall have the meaning set forth in that certain Issuer Agreement by and between Issuer and SI Securities executed prior hereto (the “Issuer Agreement”).
20/20 GENESYSTEMS, INC. SERIES C PREFERRED STOCK SUBSCRIPTION AGREEMENT NOTICE TO SUBSCRIBERSSeries C Preferred Stock Subscription Agreement • July 8th, 2020 • 20/20 GeneSystems, Inc. • Services-testing laboratories • Delaware
THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, SUBSCRIBERS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE ILLIQUID FOR AN INDEFINITE PERIOD OF TIME. NO PUBLIC MARKET EXISTS FOR THE SECURITIES.
SI Securities, LLCPlacement Agent Agreement • July 8th, 2020 • 20/20 GeneSystems, Inc. • Services-testing laboratories • New York
